Safety and Efficacy of Hizentra® in Pediatric Hematopoietic Stem Cell Recipients
Publication
, Conference
Patel, N; Heimall, JR; Younger, B; Neelands, B; Morris, D; Buckley, R; Thakar, M
Published in: JOURNAL OF CLINICAL IMMUNOLOGY
2018
Duke Scholars
Published In
JOURNAL OF CLINICAL IMMUNOLOGY
EISSN
1573-2592
ISSN
0271-9142
Publication Date
2018
Volume
38
Issue
3
Start / End Page
403 / 403
Related Subject Headings
- Immunology
- 3204 Immunology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, N., Heimall, J. R., Younger, B., Neelands, B., Morris, D., Buckley, R., & Thakar, M. (2018). Safety and Efficacy of Hizentra® in Pediatric Hematopoietic Stem Cell Recipients. In JOURNAL OF CLINICAL IMMUNOLOGY (Vol. 38, pp. 403–403).
Patel, Niraj, Jennifer R. Heimall, Beth Younger, Brittany Neelands, David Morris, Rebecca Buckley, and Monica Thakar. “Safety and Efficacy of Hizentra® in Pediatric Hematopoietic Stem Cell Recipients.” In JOURNAL OF CLINICAL IMMUNOLOGY, 38:403–403, 2018.
Patel N, Heimall JR, Younger B, Neelands B, Morris D, Buckley R, et al. Safety and Efficacy of Hizentra® in Pediatric Hematopoietic Stem Cell Recipients. In: JOURNAL OF CLINICAL IMMUNOLOGY. 2018. p. 403–403.
Patel, Niraj, et al. “Safety and Efficacy of Hizentra® in Pediatric Hematopoietic Stem Cell Recipients.” JOURNAL OF CLINICAL IMMUNOLOGY, vol. 38, no. 3, 2018, pp. 403–403.
Patel N, Heimall JR, Younger B, Neelands B, Morris D, Buckley R, Thakar M. Safety and Efficacy of Hizentra® in Pediatric Hematopoietic Stem Cell Recipients. JOURNAL OF CLINICAL IMMUNOLOGY. 2018. p. 403–403.
Published In
JOURNAL OF CLINICAL IMMUNOLOGY
EISSN
1573-2592
ISSN
0271-9142
Publication Date
2018
Volume
38
Issue
3
Start / End Page
403 / 403
Related Subject Headings
- Immunology
- 3204 Immunology
- 1107 Immunology